Genitourinary tract infection is one of the most common gynecological diseases in clinical practice. Every year, tens of millions of women worldwide seek medical treatment due to vaginitis. At the same time, the disease affects women of almost all ages, especially women of childbearing age. The treatment mainly depends on antibiotics, but the cure rate is low, and the recurrence rate can reach more than 40%. At present, when using antibiotics to treat vaginitis clinically, although it can effectively kill a large number of pathogenic bacteria in a short time, it fails to restore a healthy vaginal microenvironment, has a high recurrence rate, and is difficult to cure completely. More than half of the patients relapse within half a year after treatment. It also increases the risk of women suffering from endometritis, miscarriage and premature delivery.
Lactobacillus curlicus is an absolutely dominant strain of vaginal bacteria in Chinese women. It was identified and screened from hundreds of lactic acid bacteria isolated from the vagina of 100 young healthy women. It can effectively antagonize pathogenic bacteria of women's reproductive tract (including Staphylococcus aureus, Escherichia coli, Candida albicans, etc.), and has a high adhesion ability with vaginal epithelial cells. The lactobacillus living bacteria preparation developed has the advantages of safety, reliability, less adverse reactions, good effect, etc., improving the treatment effect of women's urogenital tract infection, and fundamentally restoring the vaginal microenvironment, which is beneficial to women's health.
Formula | Composition | Function |
Probiotics | Lactobacillus convolvulus Lcr-MH175 | The lactobacillus with the highest abundance in the vagina of healthy women, a strain owned by Meihua Company, was isolated from the vagina of 100 young healthy women. It has a strong ability to produce acid and H2O2, and can inhibit the infection of vaginal harmful bacteria; Strong colonization ability. Curly is a domestic blank, and it is a unique drug reserve strain of Harbin Meihua Biotechnology Co. 1 article published and 1 patent granted. |
Natural biological materials | Lactose | Lactic acid bacteria ferment lactose to produce lactic acid and maintain acidic environment. |
Lactic acid | Directly adjust acidic environment. | |
Chitosan | Antibacterial, film-forming, moisturizing, repairing, and vaginal contraction. |
Packing:
Packages | Probiotics Powder | Probiotics Tablet | ||
Powder | Packing size | Tablet | Packinbg Size | |
Bag | 2.0g | 100*25mm | 0.6g/tablet, 3tablets | 70*55mm
|
Box | 30bags | 120*85*50mm | 30bags | 120*85*50mm |
Carton | 50Boxes | 460*270*280mm | 50Boxes | 460*270*280mm |